Publications by authors named "Todd Katz"

Claim this Profile
F
First-dose effects with intravitreal aflibercept in wet age-related macular degeneration: a post-hoc analysis of VIEW-1 and VIEW-2 phase 3 studies.
Amin Kherani, Lynne R Brunck, Todd A Katz, John Galic

Can J Ophthalmol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Baseline Subretinal Fluid on Treatment Outcomes in VIVID-DME and VISTA-DME Studies.
Jean-Francois Korobelnik, Chengxing Lu, Todd A Katz, Dilsher S Dhoot, Anat Loewenstein

Ophthalmol Retina· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of visual outcomes in patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor therapy: post hoc analysis of the VIEW studies.
Paolo Lanzetta, Alan F Cruess, Salomon Y Cohen, Jason S Slakter, Todd Katz

Acta Ophthalmol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS).
Jana Stefanickova, Jose Cunha-Vaz, Michael Ulbig, Ian Pearce, Alvaro Fernández-Vega Sanz, Todd Katz

Acta Ophthalmol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies.
Paul Mitchell, Ian McAllister, Michael Larsen, Giovanni Staurenghi, Jean-Francois Korobelnik, Todd A Katz

Ophthalmol Retina· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies.
Giovanni Staurenghi, Nicolas Feltgen, Jennifer J Arnold, Todd A Katz, Carola Metzig

Br J Ophthalmol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Baseline Central Retinal Thickness on Outcomes in the VIVID-DME and VISTA-DME Studies.
Edoardo Midena, Mark Gillies, Todd A Katz, Carola Metzig, Chengxing Lu

J Ophthalmol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Characteristics of the Fellow Eye in Patients with Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the VIEW Studies.
Sebastian Wolf, Francesco Bandello, Anat Loewenstein, Jason Slakter, Todd Katz

Ophthalmologica· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials.
Sebastian M Waldstein, Christian Simader, Giovanni Staurenghi, N Victor Chong, Paul Mitchell, Todd A Katz

Ophthalmology· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis